Sanofi: Arthritis, Rheumatoid trials
The registry lists 36 Arthritis, Rheumatoid studies with Sanofi as lead sponsor. 2 are open to participants now and 14 have results posted.
Phase 1 13Phase 2 12Phase 3 10Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase 1b/2 Study of IV Sarilumab in Adult With RARecruitingNCT07704580Phase 1/2
- A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic DiseasesRecruitingNCT06647069Phase 1
- Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompletedNCT03449758Phase 4Results posted
- An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCompletedNCT02518620Phase 2Results posted
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)CompletedNCT02373202Phase 3Results posted
- Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)CompletedNCT02332590Phase 3Results posted
- A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisCompletedNCT02309359Phase 2Results posted
- A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)CompletedNCT02293902Phase 3Results posted
- A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisCompletedNCT02287922Phase 2Results posted
- To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)CompletedNCT02121210Phase 3Results posted
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)CompletedNCT01768572Phase 3Results posted
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateTerminatedNCT01764997Phase 3Results posted
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)CompletedNCT01709578Phase 3Results posted
- Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersTerminatedNCT01217814Phase 2Results posted
- Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)CompletedNCT01146652Phase 3Results posted
- Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsCompletedNCT01061736Phase 2/3Results posted
- A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi ArabiaCompletedNCT06714461
- Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male SubjectsCompletedNCT06159452Phase 1
- A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisCompletedNCT06073093Phase 2
- A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.CompletedNCT05858788Phase 1
- A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566CompletedNCT05844735Phase 1
- An Observational Study on Sarilumab-exposed PregnanciesCompletedNCT03378219
- Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT02404558Phase 1
- ALX-0061 Phase I Bioavailability Study in Healthy VolunteersCompletedNCT02101073Phase 1
- Sarilumab Effect on the Pharmacokinetics of SimvastatinCompletedNCT02017639Phase 1
- Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid ArthritisCompletedNCT01850680Phase 1
- Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis PatientsCompletedNCT01328522Phase 1
- Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) PatientsCompletedNCT01284569Phase 1/2
- Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid ArthritisCompletedNCT01063803Phase 2
- Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid ArthritisCompletedNCT01007175Phase 1/2
- Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid ArthritisCompletedNCT00959036Phase 1/2
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCompletedNCT00596206Phase 3
- Leflunomide + Methotrexate in Rheumatoid ArthritisCompletedNCT00563849Phase 4
- Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid ArthritisCompletedNCT00545454Phase 2
- Objective Study in Rheumatoid ArthritisCompletedNCT00451971Phase 4
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4